FAK-heterozygous mice display enhanced tumour angiogenesis
Open Access
- 25 June 2013
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 4 (1) , 2020
Abstract
Genetic ablation of endothelial focal adhesion kinase (FAK) can inhibit pathological angiogenesis, suggesting that loss of endothelial FAK is sufficient to reduce neovascularization. Here we show that reduced stromal FAK expression in FAK-heterozygous mice unexpectedly enhances both B16F0 and CMT19T tumour growth and angiogenesis. We further demonstrate that cell proliferation and microvessel sprouting, but not migration, are increased in serum-stimulated FAK-heterozygous endothelial cells. FAK-heterozygous endothelial cells display an imbalance in FAK phosphorylation at pY397 and pY861 without changes in Pyk2 or Erk1/2 activity. By contrast, serum-stimulated phosphorylation of Akt is enhanced in FAK-heterozygous endothelial cells and these cells are more sensitive to Akt inhibition. Additionally, low doses of a pharmacological FAK inhibitor, although too low to affect FAK autophosphorylation in vitro, can enhance angiogenesis ex vivo and tumour growth in vivo. Our results highlight a potential novel role for FAK as a nonlinear, dose-dependent regulator of angiogenesis where heterozygous levels of FAK enhance angiogenesis.Keywords
This publication has 53 references indexed in Scilit:
- Endothelial FAK is required for tumour angiogenesisEMBO Molecular Medicine, 2010
- Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic developmentJournal of Cell Biology, 2010
- Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasisCancer Letters, 2010
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 DegradationMolecular Cell, 2008
- Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progressionProceedings of the National Academy of Sciences, 2007
- Structural Basis for the Autoinhibition of Focal Adhesion KinaseCell, 2007
- Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytesJournal of Molecular and Cellular Cardiology, 2006
- Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycinCancer Cell, 2006
- The role of focal-adhesion kinase in cancer — a new therapeutic opportunityNature Reviews Cancer, 2005
- Focal adhesion kinase: in command and control of cell motilityNature Reviews Molecular Cell Biology, 2005